Tumor suppressive microRNA-193b promotes breast cancer progression via targeting DNAJC13 and RAB22A

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 11, 2014, Pages 7563-7570

  Yang, Zhaoying ^a,b   He, Miao ^c   Wang, Keren ^a,b   Sun, Guang ^a,b   Tang, Lu ^a,b   Xu, Zheli ^a,b  

^a CHINA JAPAN UNION HOSPITAL OF JILIN UNIVERSITY   (China)

^b Jilin Province Institute of Cancer Research   (China)

^c THE SECOND HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Breast cancer; microRNA; Target identification

Indexed keywords

CHAPERONE; DNAJC13 PROTEIN, HUMAN; MICRORNA; MIRN193 MICRORNA, HUMAN; RAB PROTEIN; RAB22A PROTEIN, HUMAN;

BREAST TUMOR; CELL LINE; CELL MOTION; CELL PROLIFERATION; DISEASE COURSE; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DISEASE PROGRESSION; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; MOLECULAR CHAPERONES; RAB GTP-BINDING PROTEINS;

EID: 84920120279     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Lyon F. Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. International Agency for Research on Cancer 2013; Available from: http://globocan.iarc.fr, accessed on 13/12/2013.
2. Narod SA. Bilateral breast cancers. Nat Rev Clin Oncol 2014; 11: 157-166.
3. Croce CM. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 2009; 10: 704-714.
4. Mulrane L, Klinger R, McGee SF, Gallagher WM and O'Connor DP. microRNAs: a new class of breast cancer biomarkers. Expert Rev Mol Diagn 2014; 14: 347-363.
5. Melo SA, Ropero S, Moutinho C, Aaltonen LA, Yamamoto H, Calin GA, Rossi S, Fernandez AF, Carneiro F, Oliveira C, Ferreira B, Liu CG, Villanueva A, Capella G, Schwartz S Jr, Shiekhattar R and Esteller M. A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nat Genet 2009; 41: 365-370.
6. Nicoloso MS, Spizzo R, Shimizu M, Rossi S and Calin GA. MicroRNAs--the micro steering wheel of tumour metastases. Nat Rev Cancer 2009; 9: 293-302.
7. Ma L, Reinhardt F, Pan E, Soutschek J, Bhat B, Marcusson EG, Teruya-Feldstein J, Bell GW and Weinberg RA. Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nat Biotechnol 2010; 28: 341-347.
8. Bourguignon LY, Earle C, Wong G, Spevak CC and Krueger K. Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells. Oncogene 2012; 31: 149-160.
9. Miller TE, Ghoshal K, Ramaswamy B, Roy S, Datta J, Shapiro CL, Jacob S and Majumder S. MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1. J Biol Chem 2008; 283: 29897-29903.
10. Gonzalez-Gugel E, Villa-Morales M, Santos J, Bueno MJ, Malumbres M, Rodriguez-Pinilla SM, Piris MA and Fernandez-Piqueras J. Down-regulation of specific miRNAs enhances the expression of the gene Smoothened and contributes to T-cell lymphoblastic lymphoma development. Carcinogenesis 2013; 34: 902-908.
11. Lenarduzzi M, Hui AB, Alajez NM, Shi W, Williams J, Yue S, O'Sullivan B and Liu FF. MicroRNA-193b enhances tumor progression via down regulation of neurofibromin 1. PLoS One 2013; 8: e53765.
12. Hu H, Li S, Liu J and Ni B. MicroRNA-193b modulates proliferation, migration, and invasion of non-small cell lung cancer cells. Acta Biochim Biophys Sin (Shanghai) 2012; 44: 424-430.
13. Xie C, Jiang XH, Zhang JT, Sun TT, Dong JD, Sanders AJ, Diao RY, Wang Y, Fok KL, Tsang LL, Yu MK, Zhang XH, Chung YW, Ye L, Zhao MY, Guo JH, Xiao ZJ, Lan HY, Ng CF, Lau KM, Cai ZM, Jiang WG and Chan HC. CFTR suppresses tumor progression through miR-193b targeting urokinase plasminogen activator (uPA) in prostate cancer. Oncogene 2013; 32: 2282-2291, 2291.e1-7.
14. Leivonen SK, Makela R, Ostling P, Kohonen P, Haapa-Paananen S, Kleivi K, Enerly E, Aakula A, Hellstrom K, Sahlberg N, Kristensen VN, Borresen-Dale AL, Saviranta P, Perala M and Kallioniemi O. Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines. Oncogene 2009; 28: 3926-3936.
15. Alajez NM, Lenarduzzi M, Ito E, Hui AB, Shi W, Bruce J, Yue S, Huang SH, Xu W, Waldron J, O'Sullivan B and Liu FF. MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway. Cancer Res 2011; 71: 2381-2391.
16. Shi W, Gerster K, Alajez NM, Tsang J, Waldron L, Pintilie M, Hui AB, Sykes J, P'ng C, Miller N, McCready D, Fyles A and Liu FF. MicroRNA-301 mediates proliferation and invasion in human breast cancer. Cancer Res 2011; 71: 2926-2937.
17. Tahiri A, Leivonen SK, Luders T, Steinfeld I, Ragle Aure M, Geisler J, Makela R, Nord S, Riis ML, Yakhini Z, Kleivi Sahlberg K, Borresen-Dale AL, Perala M, Bukholm IR and Kristensen VN. Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors. Carcinogenesis 2014; 35: 76-85.
18. Leivonen SK, Rokka A, Ostling P, Kohonen P, Corthals GL, Kallioniemi O and Perala M. Identification of miR-193b targets in breast cancer cells and systems biological analysis of their functional impact. Mol Cell Proteomics 2011; 10: M110. 005322.
19. Leivonen SK, Ala-Aho R, Koli K, Grenman R, Peltonen J and Kahari VM. Activation of Smad signaling enhances collagenase-3 (MMP-13) expression and invasion of head and neck squamous carcinoma cells. Oncogene 2006; 25: 2588-2600.
20. Yoshimoto N, Toyama T, Takahashi S, Sugiura H, Endo Y, Iwasa M, Fujii Y and Yamashita H. Distinct expressions of microRNAs that directly target estrogen receptor alpha in human breast cancer. Breast Cancer Res Treat 2011; 130: 331-339.
21. Li XF, Yan PJ and Shao ZM. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer. Oncogene 2009; 28: 3937-3948.
22. Thorns C, Schurmann C, Gebauer N, Wallaschofski H, Kumpers C, Bernard V, Feller AC, Keck T, Habermann JK, Begum N, Lehnert H and Brabant G. Global MicroRNA Profiling of Pancreatic Neuroendocrine Neoplasias. Anticancer Res 2014; 34: 2249-2254.
23. Heldens L, Dirks RP, Hensen SM, Onnekink C, van Genesen ST, Rustenburg F, Lubsen NH. Co-chaperones are limiting in a depleted chaperone network. Cell Mol Life Sci 2010; 67: 4035-4048.
24. Girard M and McPherson PS. RME-8 regulates trafficking of the epidermal growth factor receptor. FEBS Lett 2008; 582: 961-966.
25. Fujibayashi A, Taguchi T, Misaki R, Ohtani M, Dohmae N, Takio K, Yamada M, Gu J, Yamakami M, Fukuda M, Waguri S, Uchiyama Y, Yoshimori T and Sekiguchi K. Human RME-8 is involved in membrane trafficking through early endosomes. Cell Struct Funct 2008; 33: 35-50.
26. Kauppi M, Simonsen A, Bremnes B, Vieira A, Callaghan J, Stenmark H and Olkkonen VM. The small GTPase Rab22 interacts with EEA1 and controls endosomal membrane trafficking. J Cell Sci 2002; 115: 899-911.
27. He H, Dai F, Yu L, She X, Zhao Y, Jiang J, Chen X and Zhao S. Identification and characterization of nine novel human small GTPases showing variable expressions in liver cancer tissues. Gene Expr 2002; 10: 231-242.
28. Okamoto I, Pirker C, Bilban M, Berger W, Losert D, Marosi C, Haas OA, Wolff K and Pehamberger H. Seven novel and stable translocations associated with oncogenic gene expression in malignant melanoma. Neoplasia 2005; 7: 303-311.
29. Ogier-Denis E, Bauvy C, Cluzeaud F, Vandewalle A and Codogno P. Glucose persistence on high-mannose oligosaccharides selectively inhibits the macroautophagic sequestration of N-linked glycoproteins. Biochem J 2000; 345 Pt 3: 459-466.
30. Maldonado-Baez L and Donaldson JG. Hook1, microtubules, and Rab22: mediators of selective sorting of clathrin-independent endocytic cargo proteins on endosomes. Bioarchitecture 2013; 3: 141-146.